Table 3.
OS and clinical characteristic association by Cox regression analyses.
| Characteristics | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|
| Hazard ratio (95%, CI) | p value | Hazard ratio (95%, CI) | p value | |
| Gender/sex | ||||
| Female | Reference | |||
| Male | 1.164 (0.872-1.554) | 0.301 | ||
| Age | ||||
| ≤60 | Reference | |||
| >60 | 1.678 (1.266-2.225) | <0.001 | 1.292 (0.915-1.825) | 0.146 |
| BMI | ||||
| ≤25 | Reference | |||
| >25 | 0.819 (0.508-1.321) | 0.414 | ||
| Tumor tissue site | ||||
| Extremities | Reference | |||
| Trunk | 0.943 (0.694-1.281) | 0.707 | ||
| Head and neck | 1.222 (0.718-2.082) | 0.460 | ||
| Other specify | 2.109 (1.095-4.062) | 0.026 | ||
| T-stage | ||||
| T1 | Reference | |||
| T2 | 1.519 (0.824-2.800) | 0.180 | 2.018 (1.014-4.017) | 0.046 |
| T3 | 2.069 (1.141-3.752) | 0.017 | 3.391 (1.396-8.237) | 0.007 |
| T4 | 3.673 (2.047-6.591) | <0.001 | 6.640 (2.752-16.021) | <0.001 |
| N stage | ||||
| N0 | Reference | |||
| N1 | 1.487 (1.007-2.197) | 0.046 | 2.677 (0.907-7.906) | 0.075 |
| N2 | 1.525 (0.967-2.406) | 0.069 | 2.786 (0.918-8.452) | 0.070 |
| N3 | 2.578 (1.651-4.028) | <0.001 | 6.361 (2.085-19.413) | 0.001 |
| M stage | ||||
| M0 | Reference | |||
| M1 | 1.734 (0.915-3.287) | 0.092 | 0.608 (0.142-2.598) | 0.502 |
| Radiation therapy | ||||
| No | Reference | |||
| Yes | 0.953 (0.674-1.348) | 0.785 | ||
| Pathologic stage | ||||
| Stage I | Reference | |||
| Stage II | 1.566 (1.041-2.356) | 0.031 | 0.603 (0.288-1.261) | 0.179 |
| Stage III | 1.943 (1.315-2.871) | <0.001 | 0.374 (0.112-1.246) | 0.109 |
| Stage IV | 3.174 (1.567-6.428) | 0.001 | ||
| Race | ||||
| Asian | Reference | |||
| Black or African American | NA (NA-NA) | |||
| White | 0.223 (0.103-0.483) | <0.001 | 0.265 (0.101-0.695) | 0.007 |
| TREM2 | ||||
| Low | Reference | |||
| High | 0.734 (0.561-0.961) | 0.024 | 0.635 (0.459-0.879) | 0.006 |